Skip to search formSkip to main contentSkip to account menu

robalzotan

Known as: 3-N,N-dicyclobutylamino-8-fluoro-3,4-dihydro-2H-1-benzopyran-5-carboxamide hydrogen tartrate monohydrate 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2013
2013
A stereoselective synthesis of bicyclic primary or secondary amines, based on tetralin or chroman structural moieties, is… 
2006
2006
5-Hydroxytryptamine (5-HT, serotonin) is widely distributed in the serotonergic neurons in the CNS with the cell bodies in the… 
2005
2005
Central serotonergic neurones control reflex parasympathetic outflow to the heart, airways and bladder in a number of species… 
Highly Cited
2003
Highly Cited
2003
Systemic administration of the muscarinic-receptor antagonists atropine and scopolamine produces cognitive deficits in humans… 
2003
2003
RationaleThe serotonin 5-HT1A receptor has been ascribed a putative role in the pathophysiology and drug treatment of depression… 
2000
2000
  • H. A. Mucke
  • Current opinion in investigational drugs
  • 2000
  • Corpus ID: 46577360
AstraZeneca (formerly Astra) is developing robalzotan, a 5-HT1A antagonist, for the potential treatment of depression and anxiety…